Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2005-006209-16-IT
EUCTR2005-006209-16-IT
Active, not recruiting
Not Applicable

Evaluation of the role of 18F-di-idrossi-fenil-alanina 18F-DOPA in images diagnostic by Positron Emission Tomography PET in study of human neuroendocrin neoplasia. - ND

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 sites100 target enrollmentMay 9, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Enrollment
100
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 9, 2006
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

Eligibility Criteria

Inclusion Criteria

  • •Adult subjects age 18 years of both sex, carriers of neuroendocrin neoplasie. Patients in pediatric age affections from neuroblastoma
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •\- subject unsound of mind; \- age 18 years; \- women in pregnancy; \- women in breast\-feeding; \- patients in emergency situation.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A study of usefulness of [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the initial staging and assessment of response to treatment in locally advanced breast cancerHealth Condition 1: null- patients with locally advanced breast cancer
CTRI/2018/04/013455Sri Venkateswara Institute of Medical Sciences
Completed
Not Applicable
18-Fluorothymidine positron emission tomography (18-FLT PET/CT) to assess tumour proliferation during radical radiotherapy
ISRCTN97398362Guy's and St. Thomas' NHS Foundation Trust (UK)20
Unknown
Not Applicable
Relationship Between Hypoxia and Endocrine Response in Human Breast CancerBreast CancerHypoxia
NCT01814449Fudan University130
Completed
Not Applicable
Evaluation of 3'-deoxy-3'-[18F]fluorothymidine -PET and diffusion weighted imaging -MRI in patients with early stage non-small cell lung cancer treated with a platinum-based doublet as preoperative chemotherapy.Lungcancernon-small cell lung cancer10038666
NL-OMON42040European Organisation for Research in Treatment of Cancer (EORTC)4
Active, not recruiting
Phase 1
Experimental study to evaluate the effect of PET/TC using 18F-PSMA label in the management of patients with prostate cancer.Prostate cancerMedDRA version: 20.0Level: LLTClassification code 10029002Term: Neoplasm of the prostateSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2019-002000-41-ITISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI (IRST) S.R.L. IRCCS500